Automated Oligonucleotide & RNA Antisense Drug Foundry Cleanroom Cap Rate 2026

Underwrite GMP Class A/B continuous solid-phase oligonucleotide synthesis and chromatography purification cleanroom suites for antisense RNA therapeutics, $440/sqft base lease rates, and exit cap rates.

Underwriting Assumptions

Oligo Synthesis Cleanroom Footprint (sqft)

NNN Base Lease Rate ($/sqft/yr)

Turnkey GMP Oligo Foundry Acquisition ($)

Target Exit Capitalization Rate (%)

Projected Economics

Net Operating Income (NOI)

Going-In Capitalization Rate

Stabilized Institutional Valuation